NAVICAN PRECISION CANCER CARE Logo (WIPO, 07.11.2017)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke NAVICAN PRECISION CANCER CARE wurde als Wortmarke am 07.11.2017 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1389030 |
| Länder | 
|
| Basismarke |
Nr. ,
22. Oktober 2024
|
| Anmeldedatum | 07. November 2017 |
| Ablaufdatum | 07. November 2027 |
Markeninhaber
36 South State Street, Suite 2200
Salt Lake City UT 84111
US
Salt Lake City UT 84111
US
Markenvertreter
201 South Main Street,
Suite 1100
US
Waren und Dienstleistungen
01
Assays and reagents for use in genetic research
05
Medical diagnostic reagents and assays for testing of tumor
tissue or body fluids
10
Medical specimen collection kits containing a slide cassette
and envelope for collection of cells, tissue, blood, urine,
other body fluids and fecal matter
35
Pharmaceutical procurement services, namely, purchasing
pharmaceuticals for others; pharmaceutical cost management
services and drug utilization review services; assisting
patients in enrolling in diagnostics and pharmaceutical
reimbursement programs of others; providing business,
pricing, reimbursement benchmarking and other market
intelligence information in the field of drug reimbursement
for prescribers, patients and the pharmaceutical industry;
providing business, pricing, reimbursement benchmarking and
other market intelligence information in the field of
diagnostics reimbursement for providers and patients;
business administration of diagnostics and pharmacy
reimbursement programs and services; business management and
consultation services in the field of specialty pharmacy,
namely, assisting patients and providers with pharmaceutical
reimbursement; business management and consultation services
in the field of off label pharmaceuticals, namely, assisting
patients and providers with pharmaceutical reimbursement;
business management services in the field of diagnostics,
namely, assisting patients and providers with diagnostics
reimbursement; promoting collaboration within the
scientific, research and medical communities to achieve
advances in the fields of healthcare and pharmaceuticals;
and business management of comprehensive programs involving
drug therapy
36
Financial management services in relation to pharmaceutical
benefits; insurance claims processing in the field of
diagnostics and pharmaceutical claims; providing
information, including in the form of statistics, about
patient reimbursement and insurance coverage for diagnostics
and pharmaceuticals through a database; reimbursement
payment processing in the field of diagnostics and
pharmaceutical claims; providing information in the field of
financial support options and resources for prescribers,
patients and the pharmaceutical industry; providing patient
reimbursement and insurance coverage information in the
field of drug reimbursement for prescribers, patients and
the pharmaceutical industry; providing patient reimbursement
and insurance coverage information in the field of
diagnostics reimbursement for providers and patients; and
financial management of diagnostics and pharmacy
reimbursement programs and services
42
Medical, clinical and scientific research in the field of
oncology, namely, research relating to genetic diagnostic
assays and pharmaceuticals for personalized diagnosis,
treatment and prevention of cancer; scientific and
technological services, namely, research services for
medical purposes in the field of genetic diagnostic assays
and pharmaceuticals research for personalized diagnosis,
treatment and prevention of cancer; providing medical and
scientific research information and scientific consulting in
the field of genetic diagnostic assays and pharmaceuticals
for diagnosis, treatment and prevention of cancer;
conducting early evaluations in the field of new genetic
diagnostics assays and pharmaceuticals; development,
evaluation and medical and scientific research of genetic
diagnostic assays for personalized diagnosis, treatment and
prevention of cancer; laboratory research services relating
to genetic diagnostic assays for personalized diagnosis,
treatment and prevention of cancer; providing medical and
scientific research information in the field of genetic
diagnostic assays, pharmaceuticals, clinical trials and
genetics; technical consulting related to scientific and
medical studies in the field of genetic diagnostic assay and
pharmaceuticals for personalized diagnosis, treatment and
prevention of cancer; basic and clinical research in the
field of oncology, namely, researching genetic diagnostic
assays and pharmaceuticals for personalized diagnosis,
treatment and prevention of cancer; providing medical and
scientific research information in the field of genetic
diagnostic assays, pharmaceuticals and clinical trials for
personalized diagnosis, treatment and prevention of cancer;
custom design and development of chemical reagants and
multiplex sequencing assays for personalized diagnosis,
treatment and prevention of cancer; providing medical and
scientific research information in the field of oncology
through on on-line computer database that allows for input
and collection of scientific and research data and
information relating to genetic diagnostic assays and
pharmaceuticals for diagnosis, treatment and prevention of
cancer; data collection for research purposes, namely, data
mining and pattern recognition, designing clinical studies,
and generating genomic data from patient samples for
personalized diagnosis, treatment and prevention of cancer;
data collection for research purposes, namely, the
collection and systematic sorting of clinical and patient
data comprising patient specific clinical data and
scientific clinical studies relating to genetic diagnostic
assays and pharmaceuticals for personalized diagnosis,
treatment and prevention of cancer; data collection for
research purposes, namely, the collection of mathematical
and statistical data, clinical data, patient data and data
of clinical studies relating to clinical response to cancer
treatments for personalized diagnosis, treatment and
prevention of cancer; compiling data for research purposes
in the field of medical science, namely, compiling patient
specific molecular and genomic data, patient specific
clinical data and scientific clinical studies for
personalized diagnosis, treatment and prevention of cancer;
hosting a website featuring technology with a web-based
interface where medical professionals can view genetic test
results and interpretations of the results by scientists and
medical professionals in the field of genomics, and select
the appropriate treatment and order the necessary
pharmaceutical products
44
Dispensing of pharmaceuticals; medical and pharmaceutical
consultation; pharmaceutical advice; pharmaceutical
compounding services; providing information relating to
diagnostic, prophylactic and therapeutic properties of
pharmaceuticals; medical services, namely, providing
personalized drug therapy management programs to cancer
patients based on the patient's genetic testing results;
genetic testing for medical purposes; genetic testing for
cancer diagnosis, treatment and prevention purposes;
providing genetic sequencing and consulting services via a
website designed to provide cancer patients and oncologists
with custom tailored information about the range of possible
treatments and drug therapies for a particular cancer;
providing information to patients and physicians via a
website to recommend cancer treatment and drug therapies
based on the patient's genetic testing results; providing
personalized drug therapy services for cancer patients; drug
utilization review dispensing services via a website,
namely, identifying cancer drug therapies based on a
patient's genetic testing results prior to dispensing
medications; developing and managing comprehensive treatment
programs involving drug therapy; physician support services
in the nature of providing consultation in the dispensing of
prescription drugs for persons with particular cancers;
providing medical evaluations of patients to determine
acceptability for participation in clinical trials;
providing healthcare counseling, screening, diagnosis,
prognosis, treatment, relapse, palliative, integrative
medicine, survivorship, and other related medical
information in the field of oncology; providing information
through a database in the field of oncology featuring
inputting and collection of data and information all for
treatment and diagnosis purposes; healthcare consultation in
the field of cancer treatment research, namely, advising
patients on cancer treatment research studies in which they
might participate for purposes of treating their conditions;
and providing information through an online searchable
database in the fields of oncology, bioinformatics, clinical
information technology, genomic data and genomic sequence
analysis for personalized diagnosis, treatment and
prevention of cancer
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 06. Juli 2022 | 2022/27 Gaz | CN | RAW: Rule 18ter(4) all goods and services protected |
| 05. September 2019 | 2019/36 Gaz | JP | Ablehnung |
| 07. August 2019 | 2019/38 Gaz | US | RAW: Partial Ceasing Effect |
| 05. Juli 2019 | 2019/32 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. Juli 2019 | 2019/27 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 23. Oktober 2018 | 2018/46 Gaz | CN | Ablehnung |
| 27. September 2018 | 2018/39 Gaz | JP | Ablehnung |
| 14. September 2018 | 2018/38 Gaz | KR | Ablehnung |
| 17. Juli 2018 | 2018/29 Gaz | EM | Ablehnung |
| 16. Juli 2018 | 2018/32 Gaz | US | RAW: Division or Merger of Basic Registration |
| 30. Mai 2018 | 2018/22 Gaz | GB | Ablehnung |
| 19. Mai 2018 | 2018/22 Gaz | SG | Ablehnung |
| 07. November 2017 | 2018/5 Gaz | US | Eintragung |
ID: 141389030